# FDA 483 - Vijay Swarup MD - May 30, 2025

Source: https://www.keypedia.com/records/483/vijay-swarup-md/29ac4b52-68fd-410d-8996-7463aae39167

> FDA 483 for Vijay Swarup MD on May 30, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vijay Swarup MD
- Inspection Date: 2025-05-30
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Vijendra Swarup, MD in Phoenix, AZ, a clinical investigator, revealed two significant observations. The firm failed to promptly report serious adverse events to the sponsor and did not conduct an investigation in accordance with the investigational plan, specifically regarding the timely sign-off of screening labs prior to subject randomization.

## Related Documents

- [483 - 2025-05-30](https://www.keypedia.com/records/483/vijay-swarup-md/6349a3b0-bd5d-42e5-9321-c90404dfea81)

## Related Officers

- [investigator](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)

Company: https://www.keypedia.com/companies/vijay-swarup-md/949889c3-96db-41d3-9702-304c9f8e7813

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face